The Scientific Advisory Board is composed of scientists with professional expertise in research. These scientific advisors provide advice regarding the Company's proposed research and development activities.
Dr. Daniel J. Drucker

Professor of Medicine and Director of the Banting and Best Diabetes Center at the Toronto General Hospital, University of Toronto. Dr. Drucker is a leading diabetes researcher and has made significant discoveries. Dr. Alex Rabinovitch

Professor of Medicine, Medical Microbiology and Immunology, Department of Medicine, University of Alberta. Dr. Rabinovitch is Head of the Muttart Diabetes Center and is a world leader in diabetes research at the University of Alberta Medical Center in Edmonton. Dr. Jay S. Skyler

Professor of Medicine, Pediatrics and Psychology, University of Miami. Dr. Skyler is also the Director of the Division of Endocrinology, Diabetes and Metabolism, Department of Medicine, at the University of Miami School of Medicine and the Chairman of the NIDDK Type 1 Diabetes TrialNet Study Group. Dr. Gordon C. Weir

Professor of Medicine, Harvard Medical School, Diabetes Research and Wellness Foundation Chair, Head, Joslin's Section on Islet Transplantation and Cell Biology. He currently is Editor-in-chief of the journal Diabetes. Dr. Weir is one of the leading authorities on islet replacement therapy for diabetes and for over 25 years has made significant contributions to both basic and clinical research in diabetes. Dr. Bernard Zinman

Professor of Medicine, University of Toronto. Dr. Zinman is also the Director of the Leadership Sinai Center for Diabetes Research and Senior Scientist, Samuel Lunenfeld Research Institute, Toronto, Ontario. Dr. Peter St. George-Hyslop

Professor in the Department of Medicine, Division of Neurology, University of Toronto. Dr. St George-Hyslop is also the Director of Center for Research in Neurodegenerative Diseases, University of Toronto, and neurologist, University Health Network, Toronto, Ontario.